What Are the Long-Term Outcomes of SSRI Use in Adolescents?

Purpose of the Post

Selective Serotonin Reuptake Inhibitors (SSRIs) have become a common intervention for adolescents struggling with depression and anxiety. As Christian mental health professionals, we are called to care not only about clinical efficacy but also about long-term well-being, spiritual formation, and ethical responsibility in treatment decisions. This blog post explores the long-term outcomes of SSRI use in adolescents, integrating research findings with biblical wisdom and clinical discernment.

Current Research on SSRIs in Adolescents

SSRIs are often prescribed as a first-line pharmacological treatment for major depressive disorder (MDD) and anxiety in adolescents due to their relatively favorable safety profile compared to other classes of antidepressants (Walkup et al., 2008). However, research on long-term outcomes is still evolving.

A longitudinal review by Cosgrove et al. (2023) examined SSRI use in children and adolescents and found mixed outcomes. While many youth experience symptom reduction and improved functioning within 6–12 months, questions remain about neurodevelopmental impacts, emotional blunting, and dependence on pharmacological coping.

Some key findings include:

• Symptom recurrence: Up to 50% of adolescents experience a relapse within five years of SSRI treatment, especially if therapy was not combined with psychotherapy (March et al., 2007).

• Cognitive and emotional flattening: Some individuals report emotional numbness or decreased affect, which can persist after discontinuation in a small subset (Cartwright et al., 2016).

• Discontinuation syndrome: Adolescents may develop symptoms such as dizziness, irritability, and flu-like sensations when stopping SSRIs, especially if tapered too quickly (Fava et al., 2015).

• Unknown effects on brain maturation: Because adolescence is a period of significant brain growth, SSRIs may interact with developing serotonin systems in ways not yet fully understood (Cipriani et al., 2016).

However, it’s important to recognize that SSRIs do help reduce suicidal ideation in many cases and may prevent immediate crises when monitored closely and paired with supportive care (Bridge et al., 2007).

Clinical and Ethical Considerations

Christian therapists must wrestle with questions of dependence, stewardship of the body, and informed consent. The Apostle Paul exhorts believers:

“But test everything; hold fast what is good.” (1 Thessalonians 5:21, ESV)

Exegesis of 1 Thessalonians 5:21

This exhortation is part of Paul’s closing ethical imperatives to the Thessalonian church. The Greek word dokimazete ("test") implies discerning the authenticity of something. Sproul (2011) notes that this call to discernment is not skepticism, but spiritual maturity—evaluating whether a teaching or practice aligns with the character of God. Alistair Begg (2008) affirms that we must “hold fast” to what promotes righteousness, justice, and life.

In the counseling context, this verse urges therapists to critically examine tools like SSRIs, not dismissing them outright, but discerning whether they align with the goal of healing that honors God.

SSRIs may be a wise temporary provision for adolescents in acute distress. But clinicians must not overlook non-pharmacological options, such as:

• Trauma-informed cognitive behavioral therapy

• Biblical counseling and spiritual formation

• Family systems work

• Lifestyle changes: sleep, nutrition, exercise, and social connection

When adolescents are treated holistically—mind, body, and spirit—they are more likely to thrive long-term.

Biblical Reflection and Scriptural Exegesis

“The LORD is near to the brokenhearted and saves the crushed in spirit.” (Psalm 34:18, ESV)

Exegesis of Psalm 34:18

This verse, within a thanksgiving psalm by David, assures God’s closeness in affliction. The Hebrew terms nishberei-lev (brokenhearted) and dakkei-ruach (crushed in spirit) convey profound emotional suffering. Calvin (1557/2009) writes that God’s nearness here is not abstract but covenantal mercy—God draws near in compassion, not just observation. Ironside (1908) reflects on this as the Lord’s intimacy with those emotionally afflicted, a reassurance for both client and counselor.

Clinical implication: medications may reduce distress, but only the presence of God brings redemptive healing. Therapy that includes spiritual presence affirms this eternal truth.

“Give your servant therefore an understanding mind to govern your people, that I may discern between good and evil...” (1 Kings 3:9, ESV)

Exegesis of 1 Kings 3:9

Solomon’s request for wisdom reveals that discernment is the foundation of leadership. The Hebrew phrase lev shomea means “a hearing heart”—a heart attuned to God’s voice. Ryle (1865) emphasizes that this request for understanding should mark all spiritual leadership. Sproul (2011) sees this as a prayer for moral clarity, not merely intellectual sharpness.

Christian mental health professionals likewise must pray for “a hearing heart” to know when to initiate or wean a client off SSRIs. What is clinically expedient may not be spiritually formative.

Summary

The long-term outcomes of SSRIs in adolescents include both potential benefits and risks. While many adolescents benefit symptomatically in the short term, long-term effects such as emotional blunting, relapse, and uncertain neurological consequences warrant cautious, discerning use—especially in light of our calling to shepherd young lives with Christlike care.

Through the lens of 1 Thessalonians 5:21, Psalm 34:18, and 1 Kings 3:9, we are reminded that Christian counselors are not merely technicians—we are shepherds, listeners, and spiritual midwives. We must evaluate each treatment in light of God’s truth, always aiming to heal not just symptoms but souls.

References

Begg, A. (2008). Brave by Faith: God-Sized Confidence in a Post-Christian World. The Good Book Company.

Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., & Brent, D. A. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297(15), 1683–1696. https://doi.org/10.1001/jama.297.15.1683

Calvin, J. (2009). Commentary on the Book of Psalms (Vol. 1, J. Anderson, Trans.). Christian Classics Ethereal Library. (Original work published 1557)

Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016). Long-term antidepressant use: Patient perspectives of benefits and adverse effects. Patient Preference and Adherence, 10, 1401–1407. https://doi.org/10.2147/PPA.S110632

Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., ... & Geddes, J. R. (2016). Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis. The Lancet, 388(10047), 881–890. https://doi.org/10.1016/S0140-6736(16)30385-3

Cosgrove, L., Khan, N., & Erlich, D. R. (2023). Antidepressant use in children and adolescents: The need for more meaningful long-term research. Ethical Human Psychology and Psychiatry, 25(1), 29–41. https://doi.org/10.1891/EHPP-2022-0004

Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: A systematic review. Psychotherapy and Psychosomatics, 84(2), 72–81. https://doi.org/10.1159/000370338

Ironside, H. A. (1908). Notes on the Psalms. Loizeaux Brothers.

March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., ... & Severe, J. (2007). The Treatment for Adolescents With Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry, 64(10), 1132–1144. https://doi.org/10.1001/archpsyc.64.10.1132

Ryle, J. C. (1865). Expository Thoughts on the Gospels. London: William Hunt.

Sproul, R. C. (2011). Can I Know God’s Will? Reformation Trust Publishing.

Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., ... & Kendall, P. C. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine, 359(26), 2753–2766. https://doi.org/10.1056/NEJMoa0804633

AI Disclosure

This blog post was created with the assistance of AI technology to ensure accuracy, thorough research, and clarity. While the content reflects a blend of machine efficiency and human oversight, readers are encouraged to consult professional ethical guidelines and faith-based counseling resources for further guidance.